In established CeD, gluten ingestion drives cytokine (interleukin-2, IL-2) release from specific CD4+ T cells that can be measured in the plasma within two hours and correlates with severity and onset of acute symptoms [29,30,31,32]. The gene discussed is IL2; the disease is cranioectodermal dysplasia.